Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression

International Journal of Cancer

Volumn 136, Issue 8, 2015, Pages 1803-1813

  Martinson, Holly A ^a   Jindal, Sonali ^b   Durand Rougely, Clarissa ^a   Borges, Virginia F ^a   Schedin, Pepper ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Immune modulation; Macrophages; Myeloid derived suppressor cells; Postpartum breast cancer; Regulatory T cells

Indexed keywords

INTERLEUKIN 10; NEUTRALIZING ANTIBODY; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL TRANSPORT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; IMMUNOCOMPETENT CELL; INVOLUTION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MAMMARY GLAND INVOLUTION; MOUSE; NONHUMAN; PUERPERIUM; REGULATORY T LYMPHOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ANIMAL; BAGG ALBINO MOUSE; BREAST; BREAST TUMOR; C57BL MOUSE; DISEASE COURSE; IMMUNOLOGY; MALE; MAMMARY GLAND; MIDDLE AGED; PATHOLOGY; UDDER; WOUND HEALING; YOUNG ADULT;

ADULT; ANIMALS; BREAST; BREAST NEOPLASMS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-10; MALE; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MIDDLE AGED; POSTPARTUM PERIOD; WOUND HEALING; YOUNG ADULT;

EID: 84922664182     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29181     Document Type: Article

References (51)

1. Lund LR, Romer J, Thomasset N, et al. Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development 1996;122:181-93.
2. Schedin P, Mitrenga T, McDaniel S, Kaeck M. Mammary ECM composition and function are altered by reproductive state. Mol Carcinog 2004;41:207-20.
3. Schedin P, O'Brien J, Rudolph M, et al. Microenvironment of the involuting mammary gland mediates mammary cancer progression. J Mammary Gland Biol Neoplasia 2007;12:71-82.
4. O'Brien J, Lyons T, Monks J, et al. Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am J Pathol 2010;176:1241-55.
5. Lyons TR, O'Brien J, Borges VF, et al. Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med 2011;17:1109-15.
6. Schedin P. Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 2006;6:281-91.
7. Lyons TR, Schedin PJ, Borges VF. Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia 2009;14:87-98.
8. Callihan EB, Gao D, Jindal S, et al. Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancyassociated breast cancer. Breast Cancer Res Treat 2013;138:549-59.
9. Clarkson RW, Wayland MT, Lee J, et al. Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res 2004;6:R92-109.
10. Hughes K, Wickenden JA, Allen JE, Watson CJ. Conditional deletion of Stat3 in mammary epithelium impairs the acute phase response and modulates immune cell numbers during postlactational regression. J Pathol 2012;227:106-17.
11. Nguyen AV, Pollard JW. Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution. Development 2000;127:3107-18.
12. Monks J, Smith-Steinhart C, Kruk ER, et al. Epithelial cells remove apoptotic epithelial cells during post-lactation involution of the mouse mammary gland. Biol Reprod 2008;78:586-94.
13. Stein T, Morris JS, Davies CR, et al. Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res 2004;6:R75-91.
14. O'Brien J, Martinson H, Durand-Rougely C, Schedin P. Macrophages are crucial for epithelial cell death and adipocyte repopulation during mammary gland involution. Development 2012;139:269-75.
15. Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004;25:677-86.
16. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006;66:605-12.
17. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010;141:39-51.
18. Morris VL, Tuck AB, Wilson SM, et al. Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines. Clin Exp Metastasis 1993;11:103-12.
19. Park JE, Barbul A. Understanding the role of immune regulation in wound healing. Am J Surg 2004;187:11S-6S.
20. DeNardo DG, Brennan DJ, Rexhepaj E, et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov 2011;1:54-67.
21. Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 2006;42:717-27.
22. Deininger MH, Seid K, Engel S, et al. Allograft inflammatory factor-1 defines a distinct subset of infiltrating macrophages/microglial cells in rat and human gliomas. Acta Neuropathol 2000;100:673-80.
23. Bystrom J, Evans I, Newson J, et al. Resolutionphase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood 2008;112:4117-27.
24. Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011;11:762-74.
25. Talmadge JE, Gabrilovich DI. History of myeloidderived suppressor cells. Nat Rev Cancer 2013;13:739-52.
26. Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009;182:4499-506.
27. Xu W, Roos A, Schlagwein N, et al. IL-10-producing macrophages preferentially clear early apoptotic cells. Blood 2006;107:4930-7.
28. Sato Y, Ohshima T, Kondo T. Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing. Biochem Biophys Res Commun 1999;265:194-9.
29. Movahedi K, Guilliams M, Van den Bossche J, et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008;111:4233-44.
30. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005;5:953-64.
31. Leek RD, Lewis CE, Whitehouse R, et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996;56:4625-9.
32. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002;196:254-65.
33. Bolpetti A, Silva JS, Villa LL, Lepique AP. Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth. BMC Immunol 2010;11:27.
34. Stolina M, Sharma S, Lin Y, et al. Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J Immunol 2000;164:361-70.
35. Hagenbaugh A, Sharma S, Dubinett SM, et al. Altered immune responses in interleukin 10 transgenic mice. J Exp Med 1997;185:2101-10.
36. Schedin P, Strange R, Mitrenga T, et al. Fibronectin fragments induce MMP activity in mouse mammary epithelial cells: evidence for a role in mammary tissue remodeling. J Cell Sci 2000;113:795-806.
37. O'Brien J, Hansen K, Barkan D, et al. Non-steroidal anti-inflammatory drugs target the protumorigenic extracellular matrix of the postpartum mammary gland. Int J Dev Biol 2011;55:745-55.
38. Maller O, Martinson H, Schedin P. Extracellular matrix composition reveals complex and dynamic stromal-epithelial interactions in the mammary gland. J Mammary Gland Biol Neoplasia 2010;15:301-18.
39. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 2007;127:514-25.
40. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005;6:1191-7.
41. Fadok VA, Bratton DL, Konowal A, et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998;101:890-8.
42. Voll RE, Herrmann M, Roth EA, et al. Immunosuppressive effects of apoptotic cells. Nature 1997;390:350-1.
43. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012;12:253-68.
44. Murphy TJ, Ni Choileain N, Zang Y, et al. CD41CD251 regulatory T cells control innate immune reactivity after injury. J Immunol 2005;174:2957-63.
45. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315:1650-9.
46. Hobson J, Gummadidala P, Silverstrim B, et al. Acute inflammation induced by the biopsy of mouse mammary tumors promotes the development of metastasis. Breast Cancer Res Treat 2013;139:391-401.
47. Stuelten CH, Barbul A, Busch JI, et al. Acute wounds accelerate tumorigenesis by a T celldependent mechanism. Cancer Res 2008;68:7278-82.
48. Fleming JM, Miller TC, Quinones M, et al. The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo. BMC Med 2010;8:27.
49. Gupta PB, Proia D, Cingoz O, et al. Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. Cancer Res 2007;67:2062-71.
50. Iyer V, Klebba I, McCready J, et al. Estrogen promotes ER-negative tumor growth and angiogenesis through mobilization of bone marrow-derived monocytes. Cancer Res 2012;72:2705-13.
51. Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 Micro-RNA, and IL6 links inflammation to cell transformation. Cell 2009;139:693-706.